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THERE is some anecdotal evidence that oxygen-ozone
therapy may be beneficial in some human diseases.
However so far only a few biochemical and pharma-
codynamic mechanisms have been elucidated. On the
basis  of  preliminary  data  we  postulated  that  con-
trolled ozone administration would promote an oxi-
dative preconditioning preventing the hepatocellular
damage mediated by free radicals. Six groups of rats
were classified as follows: (1) negative control, using
intraperitoneal  sunflower  oil;  (2)  positive  control
using  carbon  tetrachloride  (CCl4)  as  an  oxidative
challenge; (3) oxygen-ozone, pretreatment via rectal
insufflation  (15  sessions)  and  after  it,  CCl4;  (4)
oxygen, as group 3 but using oxygen only; (5) control
oxygen-ozone, as group 3, but without CCl4; group (6)
control oxygen, as group 5, but using oxygen only.
We  have  evaluated  critical  biochemical  parameters
such as levels of transaminase, cholinesterase, super-
oxide dismutase, catalase, phospholipase A, calcium
dependent  ATPase,  reduced  glutathione,  glucose  6
phosphate  dehydrogenase  and  lipid  peroxidation.
Interestingly, in spite of CCl4 administration, group 3
did not  differ from  group  1,  while groups 2 and 4
showed significant differences from groups 1 and 3
and  displayed  hepatic  damage.  To  our  knowledge
these are the first experimental results showing that
repeated administration of ozone in atoxic doses is
able to induce an adaptation to oxidative stress thus
enabling  the  animals  to  maintain  hepatocellular
integrity after CCl4 poisoning.
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Introduction
Ozone (O3) has been used as a therapeutical agent for
the  treatment  of  different,  apparently  nonrelated
diseases and beneficial effects have been observed in
cerebrovascular ischaemia,
1 chronic ulcers,
2 arterio-
sclerosis  obliterans,
3 retinitis  pigmentosa,
4 humoral
immunity  deficiency,
5 hepatic  steatosis,
6 and  heart
ischaemia.
7 In  spite  of  these  encouraging  results
obtained with ozonetherapy, its clinical use remains
controversial  due  to  the  scarce  knowledge  of  the
biochemical  and  pharmacodynamic  mechanisms
which underlie its therapeutic action and the efficacy
in such heterogeneous pathologies. Last but not least,
O3 has been associated with environmental pollutions
and  to different  pathologies.
8–10 These factors have
contributed  to  scepticism  and  prejudice  of  official
medical authorities, delaying the acceptance of ozo-
netherapy. In  order to provide scientific support to
the aforementioned clinical data, some experimental
strategies have been developed in order to increase
our knowledge concerning its probable mechanisms
of action. On the basis of the oxidant properties of O3
and  on  the  possibility  that  specific  cell  sensors
activated  by  lipid  oxidation  products  (LOP)  may
upregulate the antioxidant system, we postulate that
O3 may  induce  an  adaptation  to  oxidative  stress.
Moreover, not only O3 could induce tolerance to itself
but  it  could  prepare  the  host  to  face  physiopatho-
logical conditions mediated by reactive oxygen spe-
cies (ROS). With the aim to demonstrate the capability
of  O3 to  promote  an  oxidative  preconditioning
process,  we  induced  hepatocellular  damage  with  a
single dose of carbon tetrachloride (CCl4), which is a
recognized organic agent able to produce a cellular
injury through generation of free radicals.
11
Materials and Methods
Animals and sample preparation
Adult female Sprague-Dawley rats (220–250 g) were
used for these studies. Rats were maintained in an air
filtered  and  temperature  conditioned  (20–22°C)
room with a relative humidity of 50–52%. Rats were
fed with  standard  commercial  pellets and  water ad
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manufactured by the Ozone Research Center (Cuba)
and  was  administered  by  rectal  insufflation.  O3
obtained  from  medical  grade  oxygen  was  used
immediately and it represented only about 3% of the
gas  (O2 +  O3)  mixture.  The  O3 concentration  is
measured  by  using  an  UV  spectrophotometer  at
254 nm  and  is  very  precise. The  ozone  dose  is  the
product of the O3 concentration (expressed as mg/l)
by the gas (O2 + O3) volume (l). By knowing the body
weight of the rat the O3 dose is calculated as 1 mg/kg.
Rats  received  15  ozone  treatments,  one  per  day,
4.4–5.0ml with O3 concentration of 50 m g/ml before
challenge with CCl4. After the last ozone treatment,
rats received CCl4 (1 ml/kg) by intraperitoneal admin-
istration of a solution of 10% CCl4 in sunflower oil.
The  animals  were  euthanized  by  ether  anaesthesia,
24 h  after  receiving  CCl4.  Immediately  after,  blood
samples were obtained from the abdominal aorta and
mixed with 3.8% sodium citrate, used as an anticoagu-
lant,  for  biochemical  determinations.  Afterwards,
some  representative  samples  of  different  liver  por-
tions  were  taken  for  histopathological  studies  and
tissue  homogenates.  Liver  homogenates  were
obtained using a tissue homogenator Edmund Bulher
LBMA  at  4°C. The  homogenates  were  prepared  by
using a 50 mM KCl/histidine buffer pH 7.4, 1:10 (w/v)
and were spun down with a Sigma Centrifuge 2K15,
at  4°C  and  8500  3 g for  20 min. The  supernatants
were taken for biochemical determinations.
Treatment schedule
The  protocol  consisted  of  six  experimental  groups
(n=60). (1) negative control group treated only with
sunflower  oil  by  intraperitoneal  route;  (2)  positive
control group using 1 ml/kg of 10% CCl4 solution; (3)
ozone (O3) group receiving 15 O3 treatments (1 mg/
kg) + CCl4 (1ml/kg); (4) oxygen (O2) group with 15
O2 treatments  (26 mg/kg)  +  CCl4 (1 ml/kg);  (5)  O3
control group with 15 O3 treatments (1 mg/kg); (6)
O2 control group with 15 O2 treatments (26 mg/kg).
Biochemical determinations
The  biochemical  parameters  were  determined  by
spectrophotometric methods using an Ultraspect Plus
Spectrophotometer  from  Pharmacia  LKB.  Aspartic
alanine  transaminase  (ASAT)  and  cholinesterase
(CHEase)  levels  were  measured  in  plasma  using
standard  commercial  kits  produced  by  Boehringer
Mannheim.  In  liver,  homogenates  were  assayed  for
total  superoxide  dismutases  (Cu/Zn  and  Mn  SODs)
activity  determining  the  capacity  of  the  enzyme  in
inhibiting  the  autoxidation  of  pyrogallol  by  50%.
12
The catalase concentration was measured through the
catalytic  activity  which  promotes  the  reduction  of
hydrogen  peroxide  (H2O2)  to  oxygen  and  water.
13
The phospholipase A activity was determined accord-
ing to a standard procedure.
14 Lipid peroxidation was
assessed by  reading thiobarbituric acid-reactive sub-
stances (TBARM).
15 The determination of the activity
of  calcium-dependent  ATPase  (Ca-ATPase)
16,17 and
glucose-6-phosphate  dehydrogenase  (G6PD)
18 were
carried out as described. After precipitation  of thiol
proteins  using  10%  TCA  the  reduced  gluthatione
levels (GSH) were determined in supernatants of 10%
w/v homogenates.
19The proteins were measured by a
standard Coomassie Blue method.
20
Histological study
Samples of rat liver were taken and fixed in neutral
10% formalin, processed and embedded in paraffin.
The  histological  sections  were  stained with  haema-
toxylin  and  eosin.  In  addition,  neutral  lipids  were
demonstrated with oil red staining in frozen sections.
From the sections embedded in paraffin  and after a
previous  study  of  the  microscopic  alterations,  the
cells with ballonic degeneration were counted at the
zone III of the Rappaport acini. Ten fields were taken,
at random, per animal with a magnification of 250 3
and the count made in a blind way by two patholo-
gists. From the frozen sections stained with oil red,
the damage area by lipidosis was calculated in other
10 fields per animal, using a morphometric software
system.
21
Statistical analysis
The  statistical  analysis  was  started  by  using  the
OUTLIERS  preliminary  tests  for  detection  of  error
values. Afterward, the Anova method (Single Way) was
used followed by homogeneity variance test (Bartlett-
Box).  In  addition,  a  multiple  comparison  test  was
used (Duncan test); values are expressed by the mean
± standard error of mean (n = 10 per group). Different
letters indicate a statistical significance of at least P <
0.05.
Results
Figure  1  shows  the  mean  values  ±  SEM  of  the
biochemical  parameters  measured  for  the  first  four
groups of treatments. Groups treated with either CCl4
or O2 + CCl4, showed a significant increase of ASAT
activity in comparison with both the control and O3 +
CCl4 groups. In contrast CHEase activity for the CCl4
and  O2 +  CCl4 treatment  groups  was  reduced
significantly in comparison with both the O3 + CCl4
and control groups. A similar trend has been observed
for SODs activity although the O2 + CCl4 group has an
enzymatic activity  significantly  lower than  the CCl4
group. Catalase levels increased in CCl4 and O2 + CCl4
treatment  groups,  while  no  modifications  were
observed  under  O3 +  CCl4 treatment  group  with
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markedly  decreased  with  CCl4 and  the  O2 +  CCl4
treatments in comparison with both the control and
O3 +  CCl4 treatment  groups. The  phospholipase A
concentration in the O3 + CCl4 group did not differ
from the control group and it was significantly lower
in  comparison  with  the  CCl4 and  the  O2 +  CCl4
treatment  groups.  The  latter  group  was  markedly
increased  in  comparison  with  the  control  group.
G6PD was significantly reduced in both the CCl4 and
O2 + CCl4 groups, while O3 treatment prior to CCl4
maintained  the  enzyme  at  a  control  level.  Inter-
estingly, the O3 treatment was also able to preserve a
normal  GSH  level  while  the  O2 treatment  +  CCl4
markedly  reduce  it.  In  line  with  these  results,  the
TBARM, as an index of lipid peroxidation, was kept
under control by the O3 treatment.
Data from group 5 (O3) and group 6 (O2), without
the final challenge with CCl4 are not shown because
they  remained  in  the  range  of  the  control  group,
except phospholipase A levels were significantly (P <
0.05)  higher  (80.3  ±  14.2)  in  the  O2 group  than
control (60.0 ± 12.0).
Table 1 shows the qualitative results of the general
hepatic  damage  (hepatocellular  necrosis,  ballonic
degeneration,  lipidosis  and  mesenchymal  reaction)
and  the  total  amount  of  cells  that  have  undergone
ballonic  degeneration  (BD).  In  spite  of  a  minimal
degree  of  general  hepatic  damage  and  a  marked
reduction in the amount of cells with BD, values from
Ozone oxidative preconditioning
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FIG. 1. The effect of ozone oxidative preconditioning in preventing CCl4 damage in rats. The white and black bars represent
either the negative or the positive controls, respectively. The hatched bars represent the situation either after O3 exposure
(diagonal lines) or after O2 exposure (horizontal lines), respectively, prior to CCl4. Values represent mean ± SEM.rats  treated  with  O3 +  CCl4 were  not  significantly
different  from  those,  highly  variable,  of  the  CCl4
treatment  group.  On  the  other  hand,  the  morpho-
metric evaluation of the hepatic damage by lipidosis
(Table 2) demonstrated a significant reduction  (P <
0.05) of the damage area in the group treated with O3
in  comparison  with  the  CCl4 treatment  group.  No
differences  were  observed  between  the  CCl4 treat-
ment group and the group treated with O2 + CCl4.
Discussion
In  order  to  test  our  hypothesis  that  prolonged
administration of judicious doses of O3 may promote
the  phenomenon  of  oxidative  preconditioning,  we
had  to  demonstrate  that  hepatocytes  can  become
resistant to the damage induced by free radicals after
CCl4 poisoning. The results obtained in the present
work  fully  support  this  postulation.  It  is  worth
remembering that  Murry et al.
22 in  1986  proposed
the concept of ‘ischaemic preconditioning’ obtained
by  several  cycles  of  brief  coronary  occlusion  even-
tually  able  to  minimize  myocardial  damage  after  a
severe heart ischaemia.
Our experimental results have shown that repeated
administration of a gas mixture composed of O2–O3
via  the  colorectal  route can  induce  a  sort  of  cross-
tolerance to free radicals released after one single dose
of CCl4. On the contrary, experimental groups (2 and
4) treated with either CCl4 or O2 + CCl4, respectively,
displayed a significant cellular damage. These results
were  well  correlated  with  the  histopathological
findings in regard to the degree of ballonic degenera-
tion  and  lipidosis.  It  must  be  pointed  out  that
administration  of  O3 in  rats  could  be  carried  out
neither by inhalation, due to its toxicity,
23,24 nor by
ozonated  autohaemotherapy  for  technical  reasons.
Nonetheless the colorectal route, although somewhat
empirical,  is  easy,  practical,  atoxic  and  has  the
rationale that  ozonated products reach the liver via
portal  circulation.
25 Taking  into  account  an  inter-
species factor based on the murine metabolic rate, a
correct  dose  of  ozone  is  1 mg/kg  in  the  rat  and
0.25 mg/kg in humans, respectively. SODs and catalase
are  recognized  scavengers  of  reactive  oxygen  spe-
cies
26 and they have been tested as therapeutic agents
against cellular damage induced by ischaemia
27,28 in
spite of their low bioavailability and antibody forma-
tion. The significant stimulation of endogenous SODs
in O3 + CCl4 group in comparison with CCl4 and O2 +
CCl4 groups, suggests cellular protection most likely
through the reduction in the availability of superoxide
anion (￿O
–
2). This result was somewhat expected on
the basis of several findings
29–31 reporting increased
activities  of  SOD,  catalase  and  peroxidases  after
chronic O3 exposure. It is noteworthy that plants can
also express a protective response to O3
32 –34 suggest-
ing that living organisms chronically exposed to  O3
have the option of either programming their death or
to react and survive by upregulating the antioxidant
defence system capable to readjust the redox balance.
Moreover in patients, we and others have found
7,25,35
that  calculated,  transient  oxidative  stresses  such  as
those obtained during a cycle of ozonated autohaemo-
therapy can also induce a state of tolerance charac-
terized  by  a  simultaneous  overexpression  of  SOD,
G6PD  and  possibly  a  reduction  of TBARM  levels in
plasma. The  rectal  insufflation  of  O3 (group  3)  is
apparently able to enhance the antioxidant system in a
coordinate fashion because the increased activity  of
catalase  on  its  own  (groups  2  and  4)  is  unable  to
quench CCl4 toxicity.
It  is known  that  an  increase of intracellular  Ca
2+
concentration plays an important role in the damage
and  cellular  death, representing  a  critical  and  early
event in the development of toxicity of hepatocytes
submitted to oxidative stress.
36 The  suggestion  that
free radicals may affect the activity of the Ca-ATPase,
thus contributing to the hepatocellular injury,
37 is well
supported by our data because the Ca-ATPase activity
was severely inhibited in groups 2 and 4 while the O3
treated group equalized the control. Indeed it has been
previously  shown  that  Ca
2+-ATPase  enzymes  have
critical thiol  groups rapidly  inactivated by  ROS.
38,39
Calcium-dependent  phospholipase  A  activity  was
decreased in the O3 + CCl4 treatment group indicating
that ozone exerted indirectly a protection against the
cellular disruption, mediated by the activation of an
enzyme which generates lysophospholipids and other
metabolites responsible for cellular lysis.  The increased
phospholipase A  activity  in  the  fourth  (O2 +  CCl4)
group suggests the participation of this enzyme in the
hepatocellular  damage noted in  the histopathologic
O. S. Le´ on et al.
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Table 1. Evaluation  of the general hepatic damage in the
three groups challenged with CCl4
Groups Degree BD
CCl4 1.4 51.0 ± 22.2ab
O3 + CCl4 0.2 6.2 ± 6.2b
O2 + CCl4 2 89.0 ± 33.0a
Degree of hepatic damage: 1, slight, 2, moderate, 3, severe.
Values are expressed by the mean ± SEM.
Table 2. Morphometric evaluation of the hepatic damage by
lipidosis
Groups Damage areas (mm2)
CCl4 0.0580 ± 0.0248a
O3 + CCl4 0.0287 ± 0.0237b
O2 + CCl4 0.0512 ± 0.0240a
Values are expressed by the mean ± SEM.studies.  CCl4 poisoning  on  its  own  caused  only  a
modest  increase  of  phospholipase  A  activity  with
respect to the control, probably due to the moderate
character of the oxidative challenge after one single
dose of CCl4. The greater cellular  damage observed
after  oxygen  administration  plus  the  hepatotoxic
treatment  indicates  the  deleterious  effect  of  hyper-
oxygenation.
10,11 Sustained levels of GSH and G6PD
can  be  taken  as  reliable  markers  of  antioxidant
defenses in the face of an oxidative challenge. Finally
the decrease in hepatic lipid peroxidation obtained in
the O3 + CCl4 group was in good agreement with the
reduction of the lipidosis observed in the histopatho-
logic  studies,  while  under  CCl4 and  O2 +  CCl4
treatments  lipid  peroxidation  levels  were  raised
significantly. Why the O3 treatment, without the final
challenge  with  CCl4 (Group  5),  did  not  show  a
significant  increase  of  antioxidant  enzymes  may  be
explained by either the fairly short treatment or, more
likely, by the fact that O3 acts best when there is an
ongoing oxidative insult.
In  conclusion,  the  present  study  contributes  to
clarify  an  important  pharmacodynamic  effect  after
prolonged  ozonetherapy  in  rats. The  phenomenon
can be described as an induction of tolerance to O3
and  ROS  generated  by  toxic  agents  and  has  been
denominated as either ‘oxidative preconditioning’, or
‘oxidative  stress  adaptation’.
25 Ozonetherapy  has
been  able  to  preserve  liver  integrity  by  inducing
either enzymes or activating metabolic pathways that
maintain  an  equilibrated redox balance.  High SODs
and GSH levels, low peroxidation and a normal Ca
2+
homeostasis  are  clear  examples  of  the  efficacy  of
ozonetherapy. We believe that the possibility shown
by appropriate ozonetherapy to upregulate the anti-
oxidant system represents a fundamental property of
this  complementary  medical  approach  and  that  O3
comes  to  typify  a  unique  drug.  In  fact  exogenous
administration  of  antioxidant  substances  such  as
ascorbic acid,  GSH,  n-acetyl cysteine,  SOD  and  the
like are useful but hardly able to dramatically reverse
a chronic oxidative stress. In this sense the improve-
ment  of  the  antioxidant  defence  is  bound  to  be
crucial  in  cancer,
40 chronic  viral  infections
41 and
neurodegenerative  diseases,
42 where  the  control  of
endogenous  oxidation  has  gone  awry  with  pro-
gressive  cell  damage.  Therefore  we  should  most
actively pursue this lead for improving the therapy of
these diseases.
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